<table style="height: 72px;" width="593">
<tbody>
<tr>
<td><a style="font-size: 20px; color: #1182b6;" href="http://www.guardanthealth.com/">AACR-NCI-EORTC Findings</a></td>
<td style="text-align: right;"><a style="font-size: 20px; color: #1182b6;" href="http://grdnth.lt/1ljDKjB" color="#1182b6">Customer Spotlight</a></td>
</tr>
<tr>
<td><a style="font-size: 20px; color: #1182b6;" href="http://grdnth.lt/1WMi2jN)">Recent Press Releases</a></td>
<td>&nbsp;</td>
</tr>
</tbody>
</table>
<br>
<div><img src="http://cdn2.hubspot.net/hubfs/480767/November/MonthlyUpdate.png" title="" width="600" height="322"></div>
<div><img src="http://cdn2.hubspot.net/hubfs/480767/November/DidYouKnow.png" title="" width="600" height="423"><br>
<div style="margin-left: -4px;"><center><img src="http://cdn2.hubspot.net/hubfs/480767/November/LungCancerGraphic.png" title="" width="615" style="max-width: 605px; width: 605px; margin: 0px -10px 0px 0px;" vspace="0" align="center"></center></div>
<div style="background-color: white; padding-bottom: 20px; border-radius: 0 0 5px 5px;"><br>
<div style="font-size: 30px; color: #231f20; width: 440px; margin-left: 80px; margin-top: -20px; font-weight: 300; line-height: 1.25em; text-align: center;">See how Guardant360 can help patients avoid repeat biopsies and get the right treatment</div>
<div style="font-size: 30px; color: #black; width: 440px; margin-left: 80px; margin-top: -20px; font-weight: 300; line-height: 1.5em; text-align: center;"></div>
<p style="line-height: 1em; text-align: center;"><span style="color: #444444;"><strong><span color="#346094" style="font-size: 24px;"><br>PATIENT</span></strong></span></p>
<p style="line-height: 1em; text-align: center;"><span color="#346094" style="color: #444444;"><span style="font-size: 24px;">74 year old female</span></span></p>
<hr style="vertical-align: middle;">
<p style="line-height: 1em; text-align: center;"><span style="color: #444444;"><strong><span color="#346094"><span style="font-size: 24px;">DIAGNOSIS</span></span></strong></span></p>
<p style="line-height: 1em; text-align: center;"><span color="#346094" style="color: #444444;"><span style="font-size: 24px;">Lung adenocarcinoma</span></span></p>
<hr style="vertical-align: middle;"><center><center>
<p style="line-height: 1em; text-align: center;"><span style="color: #444444;"><strong><span color="#346094"><span style="font-size: 24px;">GENOMIC PROFILING</span></span></strong></span></p>
<p style="line-height: 1em; text-align: center;"><span color="#346094" style="color: #444444;"><span style="font-size: 24px;">Tissue QNS</span></span></p>
</center><img src="http://cdn2.hubspot.net/hubfs/480767/November/CS1.png" title="" width="600" height="155" align="center"></center>
<div style="color: #346094; font-size: 24px;"><center>
<p style="line-height: 0.5em; margin-bottom: 15px;">03/2015</p>
<p style="line-height: 1.25em; left: 70px; width: 460px; margin-top: 15px;"><span style="color: #444444;">Tissue biopsy insufficient for genotyping</span></p>
<center><img src="http://cdn2.hubspot.net/hubfs/480767/November/CaseStudyArrow.png" title="" width="600" height="34" align="center" style="margin: 0px 0px 30px;" hspace="0"></center><center><img src="http://cdn2.hubspot.net/hubfs/480767/November/CS2.png" title="" width="600" height="155" align="center"></center>
<p style="line-height: 0.5em; margin-bottom: 15px;">03/2015</p>
<p style="line-height: 1.25em; left: 70px; width: 460px; margin-top: 15px;"><span style="color: #444444;">Avoiding repeat biopsy, Guardant360 identified <i>EGFR</i> L858R, an actionable mutation</span></p>
<center><img src="http://cdn2.hubspot.net/hubfs/480767/November/CaseStudyArrow.png" title="" style="max-width: 600px; margin: 0px 0px 30px;" align="center" hspace="0"></center><center><img src="http://cdn2.hubspot.net/hubfs/480767/November/CS3.png" title="" width="600" height="155" align="center"></center>
<p style="line-height: 0.5em; margin-bottom: 15px;">04/2015</p>
<p style="line-height: 1.25em; left: 70px; width: 460px; margin-top: 15px;"><span style="color: #444444;">First-line treatment initatied with Erlotinib</span></p>
<center><img src="http://cdn2.hubspot.net/hubfs/480767/November/CaseStudyArrow.png" title="" style="max-width: 600px; margin: 0px 0px 30px;" align="center" hspace="0"></center><center><img src="http://cdn2.hubspot.net/hubfs/480767/November/CS4.png" title="" width="600" height="155" align="center"></center>
<p style="line-height: 0.5em; margin-bottom: 15px;">06/2015</p>
<p style="line-height: 1.25em; left: 70px; width: 460px; margin-top: 15px;"><span style="color: #444444;">CT scan demonstrated partial response and <i>EGFR</i> L858R not detected in ctDNA</span></p>
</center></div>
</div>
<br>
<div style="position: relative; background-image: url('http://cdn2.hubspot.net/hubfs/480767/November/ScienceLitCornerArt.png'); background-size: 600px 360px; display: block; height: 360px; width: 600px;" title="" width="600" height="360">&nbsp;
<p style="position: absolute; bottom: 20px; width: 460px; font-size: 24px; font-weight: 300; text-align: center; margin-left: 70px; line-height: 1.50em;">New clinical validation study compares Guardant360 sequencing to tissue <br><span style="color: #00ccff;"><a style="font-size: 20px; color: #1182b6;" href="http://grdnth.lt/PLOSOneG360">Read more</a></span></p>
</div>
<br>
<div style="position: relative; background-image: url('http://cdn2.hubspot.net/hubfs/480767/November/BlueBoxForDeadlineCopy.png'); background-size: 600px 189px; display: block; height: 189px; width: 600px;" title="" width="600" height="189">
<p style="position: absolute; bottom: 0px; top: 10px; width: 520px; font-size: 30px; margin-left: 30px; line-height: 1.25em; text-align: center; margin-top: 20px;"><span style="color: #444444; font-size: 24px; font-weight: 300;">The deadline to submit abstracts to AACR is December 1, 2015 and ASCO is February 2, 2016</span><br><span style="color: #ffffff; font-size: 24px;">Abstract Information:</span> <a style="font-size: 25px; font-weight: bold; margin-left: 20px; color: white;" href="http://grdnth.lt/1SxKZyV">AACR</a><a style="font-size: 25px; font-weight: bold; margin-left: 20px; color: white;" href="http://grdnth.lt/1MNIM24">ASCO</a></p>
</div>
</div>
<div><br>
<div style="margin: 0px; border-radius: 5px; background-color: #fff; padding-bottom: 20px;"><img src="http://cdn2.hubspot.net/hubfs/480767/November/BonniePhoto.png" title="" width="600" height="477" align="center">
<p style="line-height: 1.25em; font-size: 30px; font-weight: 300; width: 400px; text-align: center; margin-left: 100px; margin-bottom: 10px;"><span style="font-size: 30px; color: #444444;">Guardant Health team walks for Lung Cancer</span></p>
<p style="line-height: 1.75em; padding: 0px 20px; text-align: center; font-weight: 300; margin-top: 10px;"><span style="font-size: 24px;">Last month Guardant Health employees turned out by the dozen for a 5k run and walk supporting the Bonnie J. Addario Lung Cancer Foundation.&nbsp;Overall, the event brought in more than $200,000.</span></p>
<p style="line-height: 1.5em; width: 270px; color: #009bde; text-align: center; margin-left: 160px;"><span style="font-size: 20px; color: #00ccff;"><a href="http://grdnth.lt/1ONBdL4" style="color: #1182b6;">Click here to learn more about the foundation's work.</a></span></p>
</div>
</div>
<br><center><span color="#346094" style="color: #346094;"><span style="font-size: 18px;"></span></span></center><center><span style="font-size: 24px; color: #346094;">If you would like to share a de-identified </span></center><center><span style="font-size: 24px; color: #346094;">case study,&nbsp;please contact us at: </span></center><center><span style="font-size: 24px; color: #00ccff;"><a style="font-size: 20px; color: #1182b6;" href="mailto:patientstories@guardanthealth.com">PatientStories@guardanthealth.com</a></span></center><center><center><br><span style="font-size: 20px;"><strong><span style="color: #808080;"> Can't get enough?<br> Read about us in the <a style="font-size: 20px; color: #1182b6;" href="http://blogs.wsj.com/venturecapital/2015/07/17/liquid-biopsy-the-key-to-active-surveillance-of-cancer-guardant-health-says/"> Wall Street Journal</a>.<br> <br> Tired of thinking Blood First?<br> Unsubscribe below.</span></strong></span></center>
<div style="height: 80px; font-size: 8px; text-align: right;">&nbsp;
<p style="line-height: 1.5em; text-align: left;"><span style="font-size: 12px;">1. Note: this number increases to 80.6% if you consider patients with at least a clinical drug trial; source: Guardant360 database</span></p>
<p style="line-height: 1.5em; text-align: left;"><span style="font-size: 12px;">2. National Lung Cancer Audit Report 2012[Internet]. 2012. Available: http://www.hqip.org.uk/assets/NCAPOP-library/NCAPOP-2012-13/Lung-Cancer-National-Audit-Report-pub-2012.pdf</span></p>
<p style="line-height: 1.5em; text-align: left;">&nbsp;</p>
</div>
</center>
<div style="margin-bottom: -15px; margin-top: 35px;">
<p style="margin-right: auto; margin-left: auto; line-height: 1em; border-radius: 5px; padding: 12px 5px; width: 250px; font-size: 18px; color: white; font-weight: bold; background-color: #a4bcc4;">SHARE THIS NEWSLETTER</p>
</div>